Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009 Apr;104(4):518-32.
doi: 10.1111/j.1360-0443.2009.02504.x.

Candidate genes for cannabis use disorders: findings, challenges and directions

Arpana Agrawal  1 , Michael T Lynskey
Affiliations
Review

Candidate genes for cannabis use disorders: findings, challenges and directions

Arpana Agrawal et al. Addiction. 2009 Apr.

Abstract

Aim: Twin studies have shown that cannabis use disorders (abuse/dependence) are highly heritable. This review aims to: (i) review existing linkage studies of cannabis use disorders and (ii) review gene association studies, to identify potential candidate genes, including those that have been tested for composite substance use disorders and (iii) to highlight challenges in the genomic study of cannabis use disorders.

Methods: Peer-reviewed linkage and candidate gene association studies are reviewed.

Results: Four linkage studies are reviewed: results from these have homed in on regions on chromosomes 1, 3, 4, 9, 14, 17 and 18, which harbor candidates of predicted biological relevance, such as monoglyceride lipase (MGLL) on chromosome 3, but also novel genes, including ELTD1[epidermal growth factor (EGF), latrophilin and seven transmembrane domain containing 1] on chromosome 1. Gene association studies are presented for (a) genes posited to have specific influences on cannabis use disorders: CNR1, CB2, FAAH, MGLL, TRPV1 and GPR55 and (b) genes from various neurotransmitter systems that are likely to exert a non-specific influence on risk of cannabis use disorders, e.g. GABRA2, DRD2 and OPRM1.

Conclusions: There are challenges associated with (i) understanding biological complexity underlying cannabis use disorders (including the need to study gene-gene and gene-environment interactions), (ii) using diagnostic versus quantitative phenotypes, (iii) delineating which stage of cannabis involvement (e.g. use versus misuse) genes influence and (iv) problems of sample ascertainment.

PubMed Disclaimer

References

    1. Degenhardt L, Chiu WT, Sampson N, Kessler RC, Anthony JC, Angermeyer M, et al. Toward a global view of alcohol, tobacco, cannabis, and cocaine use: findings from the WHO World Mental Health Surveys. PLoS Med. 2008;5:e141. - PMC - PubMed
    1. Agrawal A, Lynskey MT. Does gender contribute to heterogeneity in criteria for cannabis abuse and dependence? Results from the National Epidemiological Survey on Alcohol and Related Conditions. Drug Alcohol Depend. 2007;88:300–307. - PMC - PubMed
    1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders. American Psychiatric Association; Washington, DC: 1994.
    1. Office of Applied Studies S. A. a. M. H. S. A. Treatment Episode Data Set (TEDS) 2008. Http://Wwwdasis Samhsa Gov/Webt/Quicklink/US06 Htm.
    1. Agrawal A, Lynskey MT, Bucholz KK, Martin NG, Madden PA, Heath AC. Contrasting models of genetic co-morbidity for cannabis and other illicit drugs in adult Australian twins. Psychol Med. 2007;37:49–60. - PubMed

Publication types